MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
RLYB Rallybio
- 0.950
- -0.026-2.68%
Close Dec 20 16:00 ET
- 0.970
- +0.020+2.09%
Post 20:01 ET
39.41MMarket Cap-0.61P/E (TTM)
1.000High0.932Low104.31KVolume0.970Open0.976Pre Close99.55KTurnover0.55%Turnover RatioLossP/E (Static)41.49MShares3.46052wk High0.56P/B18.03MFloat Cap0.93052wk Low--Dividend TTM18.98MShs Float25.780Historical High--Div YieldTTM7.02%Amplitude0.930Historical Low0.954Avg Price1Lot Size
About Rallybio Company
Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. Its product candidates focus on the areas of fetal and neonatal disorders, hematology, immuno-inflammation, and metabolic disease. The company was founded by Martin W. Mackay, Stephen Uden, and Jeffrey M. Fryer in January 2018 and is headquartered in New Haven, CT.
Company Profile
SymbolRLYB
Company NameRallybio
Listing DateJul 29, 2021
Issue Price13.00
Founded2018
CEODr. Stephen Uden, M.D.
MarketNASDAQ
Employees43
Fiscal Year Ends12-31
Address234 Church Street,Suite 1020
CityNew Haven
ProvinceConnecticut
CountryUnited States of America
Zip Code06510
Phone1-203-859-3820
Websitehttp://www.rallybio.com
Company Executives
- Name
- Position
- Salary
- Dr. Stephen Uden, M.D.
- Chief Executive Officer, President and Director
- 1.78M
- Jonathan I. Lieber, M.B.A.
- Principal Accounting Officer, Chief Financial Officer and Treasurer
- 1.91M
- Dr. Steven Ryder, M.D.
- Chief Medical Officer
- 1.27M
- Dr. Martin W. Mackay, PhD
- Executive Chairman of the Board
- 1.78M
- Paula Soteropoulos
- Lead Independent Director
- 113.95K
- Christine A. Nash, M.B.A.
- Independent Director
- 108.95K
- Helen M. Boudreau, M.B.A.
- Independent Director
- 118.95K
- Ronald M. Hunt, M.B.A.
- Independent Director
- 115.45K
- Dr. Wendy K. Chung, M.D.,PhD
- Independent Director
- 95.00K
- Dr. Hui Liu, M.B.A.,PhD
- Independent Director
- 111.45K
- Dr. Robert Hopfner, M.B.A.,PhD,R.Ph.
- Independent Director
- 115.45K
- Dr. Lucian Iancovici, M.D.
- Independent Director
- 111.45K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.